Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Suppression of HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05784714
What this trial is testing

NOLA GEM: Feasibility and Acceptability of an MHealth Intervention for Violence-affected PLWH

Who this might be right for
HIVMental HealthSubstance Use
Tulane University 32
Not applicableLooking for participantsNCT07125235
What this trial is testing

Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial

Who this might be right for
Behavioral InterventionViral Suppression of HIV InfectionART Adherence
University of California, San Francisco 270
Not applicableStudy completedNCT00344981
What this trial is testing

Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression

Who this might be right for
HIV InfectionsAIDS
University of Maryland, Baltimore 9
Not applicableLooking for participantsNCT06678022
What this trial is testing

Use of Unmanned Air Vehicles (Medical Drones) to Overcome Geographical Barriers to Delivery of Anti-Retroviral Therapy and Biological Samples

Who this might be right for
HIVViral Load
Makerere University 1,086
Not applicableStudy completedNCT02134431
What this trial is testing

Relationship of Tenofovir With HIV-1 Suppression in ex Vivo Tissue in Adolescents

Who this might be right for
Human Immunodeficiency Virus
University of California, Los Angeles 13
Testing effectiveness (Phase 2)Study completedNCT00000912
What this trial is testing

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 475
Not applicableStudy completedNCT00084019
What this trial is testing

Atazanavir/Ritonavir Maintenance Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableStudy completedNCT00000693
What this trial is testing

Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableLooking for participantsNCT05723653
What this trial is testing

Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention

Who this might be right for
HIV Seropositivity
University of Chicago 900
Large-scale testing (Phase 3)Ended earlyNCT00122551
What this trial is testing

Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 400
Testing effectiveness (Phase 2)Study completedNCT00976404
What this trial is testing

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir

Who this might be right for
HIV Infection
Robert L. Murphy 28
Not applicableStudy completedNCT03500172
What this trial is testing

HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)

Who this might be right for
HIV-1 Virologic Response
Johns Hopkins Bloomberg School of Public Health 1,391
Testing effectiveness (Phase 2)Study completedNCT01641809
What this trial is testing

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 244
Large-scale testing (Phase 3)WithdrawnNCT00984152
What this trial is testing

Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women

Who this might be right for
HIV-1 Infections
Rush University Medical Center
Not applicableStudy completedNCT00000627
What this trial is testing

Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome

Who this might be right for
HIV InfectionsHistoplasmosis
National Institute of Allergy and Infectious Diseases (NIAID) 90
Large-scale testing (Phase 3)Active Not RecruitingNCT04337450
What this trial is testing

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

Who this might be right for
HIV Infections
PENTA Foundation 386
Post-approval studies (Phase 4)Study completedNCT00931801
What this trial is testing

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.

Who this might be right for
HIV
Community Research Initiative of New England 43
Large-scale testing (Phase 3)Study completedNCT00460746
What this trial is testing

Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.

Who this might be right for
HIV
Tibotec, Inc 10
Large-scale testing (Phase 3)Looking for participantsNCT06507059
What this trial is testing

Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals

Who this might be right for
HIV-1-infectionNon-Adherence, Medication
Chang Gung Memorial Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00212888
What this trial is testing

Combination Vaccination Before HIV Treatment Interruption

Who this might be right for
HIV Infections
Ottawa Hospital Research Institute 52
Next Page